Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease

Nobili, Annalisa, Latagliata, Emanuele Claudio, Viscomi, Maria Teresa, Cavallucci, Virve, Cutuli, Debora, Giacovazzo, Giacomo, Krashia, Paraskevi, Rizzo, Francesca Romana +14 more·2017·Nature Communications

Cited by (521)

Items 301–400 of 521

  1. Studies on Physicochemical Properties of Biofield Treated 2,4-Dichlorophenol
    Mahendra Kumar Trivedi · 2015 · American Journal of Environmental Protection
  2. Novel cogrinding of donepezil with neurotransmitters and coumarins: characterization, physical properties and in vitro drug release study
    Weenawan Somphon, Anittha Prasertsabw, Nongpanga Jarussophon · 2019 · Materials Today Proceedings
  3. The emerging roles of particulate matter-changed non-coding RNAs in the pathogenesis of Alzheimer's disease: A comprehensive in silico analysis and review
    Hui-Xian Zeng, Shuang-Jian Qin, John Andersson, Shen-Pan Li, Qing-Guo Zeng, Jia-Hui Li, Qi-Zhen Wu, Wen-Jie Meng, Anna Oudin, Katja M. Kanninen et al. · 2024 · Environmental Pollution
  4. Chronic palmitoylethanolamide administration via slow-release subcutaneous pellets promotes neuroprotection and mitigates neuroinflammation in the Tg2576 mouse model of Alzheimer’s disease
    Daniel Tortolani, Davide Decandia, Giacomo Giacovazzo, Lucia Scipioni, Anna Panuccio, Francesca Ciaramellano, Fabiola Eugelio, Federico Fanti, Emanuele Claudio Latagliata, Livia La Barbera et al. · 2025 · Frontiers in Cellular Neuroscience
  5. Dehydrozingerone Improves Mood and Memory in Diabetic Mice via Modulating Core Neuroimmune Genes and Their Associated Proteins
    Anuradha Kesharwani, Bottu Kavya Sree, Nivedita Singh, Rahul L. Gajbhiye, Krishna Murti, Ramalingam Peraman, Krishna Pandey, Charles L. Limoli, Ravichandiran Velayutham, Vipan Kumar Parihar · 2025 · ACS Pharmacology & Translational Science
  6. Optogenetic stimulation of midbrain dopaminergic neurons rescues hippocampal synaptic plasticity deficits in a mouse model of Alzheimer’s disease
    Serena Ficchì, Emma Cauzzi, Livia La Barbera, Maria Luisa De Paolis, Gilda Loffredo, Elena Spoleti, Irene Ferrari, Luana Saba, Filippo Biamonte, Annalisa Nobili et al. · 2025 · Translational Psychiatry
  7. Excitation–inhibition imbalance as a common thread linking early Alzheimer's disease with temporal lobe epilepsy
    Nwife Getrude Okechukwu, Claudio Zaccone, Livia La Barbera, Annalisa Nobili, Marcello D’Amelio · 2025 · Experimental Neurology
  8. Dual-channel nano-carbon-liquid/liquid junction electrodes for multi-modal analysis: redox-active (dopamine) and non-redox-active (acetylcholine)
    Edappalil Satheesan Anupriya, Ran Chen, Daniel Kalski · 2024 · The Analyst
  9. Electrophysiological insights into Alzheimer's disease: A review of human and animal studies
    Kirsten Calvin, Adam M. McNeela, Amanda M. Leisgang Osse, Guncha Bhasin, Matthew Ridenour, Jefferson W. Kinney, J.M. Hyman · 2024 · Neuroscience & Biobehavioral Reviews
  10. Association of the MAOB rs1799836 Single Nucleotide Polymorphism and APOE ε4 Allele in Alzheimer’s Disease
    Mirjana Babić Leko, Matea Nikolac Perković, Gordana Nedić Erjavec, Nataša Klepac, Dubravka Švob Štrac, Fran Borovečki, Nela Pivac, Patrick R. Hof, Goran Šimić · 2021 · Current Alzheimer Research
  11. Rodent Model Preclinical Assessment of PEGylated Block Copolymer Targeting Cognition and Oxidative Stress Insults of Alzheimer’s Disease
    Sutapa Som Chaudhury, Mridula Nandi, Krishna G. Kumar, Bhuban Ruidas, Tapas Kumar Sur, Parash Prasad, Saikat Chakrabarti, Priyadarsi De, Jaya Sil, Chitrangada Das Mukhopadhyay · 2023 · Molecular Neurobiology
  12. Advanced Immunolabeling Method for Optical Volumetric Imaging Reveals Dystrophic Neurites of Dopaminergic Neurons in Alzheimer’s Disease Mouse Brain
    Soonbong Baek, Jaemyung Jang, Hyun Jin Jung, Hyeyoung Lee, Youngshik Choe · 2023 · Molecular Neurobiology
  13. Mesial temporal dopamine: From biology to behaviour
    Leah G. Mann, Daniel O. Claassen · 2023 · European Journal of Neuroscience
  14. Autophagy-Based Hypothesis on the Role of Brain Catecholamine Response During Stress
    Fiona Limanaqi, Carla Letizia Busceti, Francesca Biagioni, Francesco Fornai, Stefano Puglisi‐Allegra · 2020 · Frontiers in Psychiatry
  15. Shared Causal Paths underlying Alzheimer's dementia and Type 2 Diabetes
    Zixin Hu, Jiao, Rong, Jiucun Wang · 2019 · arXiv (Cornell University)
  16. Monoaminergic neurotransmitters are bimodal effectors of tau aggregation
    Xinmin Chang, Amanda M. Tse, Marina Fayzullina, Angela Albanese, Minchan Kim, Conner F. Wang, Zipeng Zheng, Ruchira Joshi, Christopher Kazu Williams, Shino Magaki et al. · 2025 · Science Advances
  17. Microglial clearance, neuroprotection and cognitive recovery via a novel synthetic sulfolipid in Alzheimer’s disease
    Carmela Gallo, Lucia Verrillo, Emiliano Manzo, Emma Cauzzi, Livia La Barbera, Giuseppina Sabatino, Maria Luisa De Paolis, Michele F. M. Sciacca, Giusi Barra, Elisa Peroni et al. · 2025 · Journal of Neuroinflammation
  18. Molecular and Therapeutic Targets for Amyloid-beta Plaques in Alzheimer's Disease: A Review Study
    Jaya Thomas, SAMSON KOOVAYIL WILSON · 2021 · Basic and Clinical Neuroscience Journal
  19. Systems genetics identifies methionine as a high risk factor for Alzheimer's disease
    Congmin Wang, Yu Hei, Yu Liu, Akhilesh Kumar Bajpai, Yuhe Li, Yawen Guan, Fuyi Xu, Cuifang Yao · 2024 · Frontiers in Neuroscience
  20. Repeated exposure to novelty promotes resilience against the amyloid-beta effect through dopaminergic stimulation
    Cintia Velázquez-Delgado, Eduardo Hernández-Ortiz, Lucía Landa‐Navarro, Miguel Tapia Rodríguez, Perla Moreno‐Castilla, Federico Bermúdez‐Rattoni · 2024 · Psychopharmacology
  21. Repurposing of cabergoline to improve cognitive decline in D-galactose-injected ovariectomized rats: Modulation of AKT/mTOR, GLT-1/P38-MAPK, and ERK1/2 signaling pathways
    Sheer A. Joodi, Mahmoud Mohamed Khattab, Weam W. Ibrahim · 2025 · Toxicology and Applied Pharmacology
  22. Differential Influence of Amyloid-β on the Kinetics of Dopamine Release in the Dorsal and Ventral Striatum of Rats
    Valery N. Mukhin, Ivan R. Borovets, Vadim V. Sizov, Konstantin I. Pavlov, В. М. Клименко · 2021 · Neurotoxicity Research
  23. An electrochemical reductive approach for selective determination of dopamine based on its reverse voltammetric preoxidation and intramolecular cyclization
    Dongdong Zhang, Jiatao Chen, Xia Chen · 2023 · Journal of Electroanalytical Chemistry
  24. A Mouse Model of Sporadic Alzheimer’s Disease with Elements of Major Depression
    Н. В. Бобкова, Lyubov N. Chuvakova, V. I. Kovalev, D. Y. Zhdanova, Alina Vadimovna Chaplygina, Alexander P. Rezvykh, Michael B. Evgen’ev · 2024 · Molecular Neurobiology
  25. β-Amyloid 25–35 Suppresses the Secretory Activity of the Dopaminergic System in the Rat Brain
    Valery N. Mukhin, Vadim V. Sizov, Konstantin I. Pavlov, В. М. Клименко · 2019 · Neuroscience and Behavioral Physiology
  26. Dopamine Suppresses Synaptic Responses of Fan Cells in the Lateral Entorhinal Cortex to Olfactory Bulb Input in Mice
    Shaolin Liu · 2020 · Frontiers in Cellular Neuroscience
  27. Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial
    Yan Press, Boris Punchik, Ella Kagan, Alex Berzak, Tamar Freud, Tzvi Dwolatzky · 2021 · Frontiers in Medicine
  28. β-Amyloid and Lithium Affect the Magnitude of Phasic Dopamine Release in the Shell of the Nucleus Accumbens
    Valery N. Mukhin, Ivan R. Borovets, Vadim V. Sizov, Konstantin I. Pavlov, В. М. Клименко · 2021 · Neuroscience and Behavioral Physiology
  29. Thioredoxin-1 Downregulation in the SNpc Exacerbates the Cognitive Impairment Induced by MPTP
    Xianwen Zhang, Fang Yan, Xiong Jie He, Yali Chen, Rou Gu, Xianghuan Dong, Yonghang Wei, Liping Bai, Jie Bai · 2025 · Antioxidants and Redox Signaling
  30. Disarming COX-1 to disrupt Alzheimer’s inflammatory trajectory: preclinical insights and translational promise
    Gilda Loffredo, Marcello D’Amelio · 2025 · Translational Neurodegeneration
  31. Yoga for Neurodegenerative Disorders: Therapeutic Effects, Mechanisms, and Applications in Alzheimer’s and Parkinson’s Disease
    Federico Zoila, Maria Ida de Stefano, Alessia Sgobbio, Maria Antonietta Panaro, Angela Bruna Maffione, Laura Antonucci, Benameur Tarek, Michele Massaro, Socorro Vanesca Frota Gaban, Francesca Martina Filannino et al. · 2025 · Sports
  32. Memory-Enhancing Effects of Daidzin, Possibly Through Dopaminergic and AChEergic Dependent Pathways
    Muhammad Torequl Islam, Abdullah Al Shamsh Prottay, Md. Shimul Bhuia, Md. Showkoth Akbor, Raihan Chowdhury, Siddique Akber Ansari, Irfan Aamer Ansari, Md. Amirul Islam, Catarina Martins Tahim, Henrique Douglas Melo Coutinho · 2025 · Journal of Nutrition
  33. Investigating the Synergistic Neuroprotective Effects of Plant-Derived Antioxidants and the Psychedelic N,N-Dimethyltryptamine in Alzheimer’s Disease Therapy
    Júlia Jarné‐Ferrer, Mercè Pallàs, Christian Griñán‐Ferré, Aina Bellver‐Sanchís · 2025 · Cells
  34. Accurate Neurotransmitter Release by Ultrasound‐Responsive Nanomaterials for Alleviating L‐DOPA‐Induced Dyskinesia in Parkinson's Disease
    Shengwei Jia, Xiaoxia Li, Fang Wang · 2025 · Advanced Healthcare Materials
  35. Medical risk factors, ApoE haplotype, and Alzheimer’s disease: a large-scale analysis
    Uri Elias, Lidor Gazit, Roei Zucker, Amos Stern, Michal Linial B, Gilles Allali, Tamir Ben‐Hur, Gad A. Marshall, Shahar Arzy · 2025 · The Journal of Prevention of Alzheimer s Disease
  36. Alzheimer’s Disease and Sex-Dependent Alterations in the Striatum: A Lesson from a Mouse Model
    L. La Barbera, M. D'Amelio · 2023 · Journal of Alzheimer's Disease
  37. Memory enhancing and neuroprotective effects of apomorphine in a rat model of dementia
    Huma Ikram, Rumaisa Zakir, Darakhshan Jabeen Haleem · 2024 · Metabolic Brain Disease
  38. Cognitive Effects of Almond Consumption: A Review of Animal Studies
    Kawsar Alami, Zahra Nazari, Raheel Bayat, Aqdas Bayat, Somaya Qasemi, Fereshta Karimi, Maliha Sultani, Sayed Yousof Mousavi · 2024 · Nutrition and Dietary Supplements
  39. Differential involvement of central and peripheral catecholamines between Alzheimer's disease and vascular dementia
    Xiao-Yue Hong, Siwei Li, Tian Li, Wei Chen, Yirong Li, Zhuo Wang, Yi Luo · 2024 · Heliyon
  40. Neuromodulation of Hippocampal Cells and Circuits
    J. Josh Lawrence, Stuart Cobb · 2018 · Springer series in computational neuroscience
  41. Strengthened and posterior-shifted structural rich-club organization in people who use cocaine
    Shana A. Hall, Ryan Patrick Bell, Syam Gadde, Sheri L. Towe, Muhammad Tauseef Nadeem, Peter McCann, Allen W. Song, Christina S. Meade · 2022 · Drug and Alcohol Dependence
  42. Data Preprocessing and Neural Network Architecture Selection Algorithms in Cases of Limited Training Sets—On an Example of Diagnosing Alzheimer’s Disease
    Alexander Alekseev, Leonid V. Kozhemyakin, Vladislav Nikolaevich Nikitin, Julia Bolshakova · 2023 · Algorithms
  43. Age-dependent Effects of Dopamine on Working Memory and Synaptic Plasticity in Hippocampal CA3-CA1 Synapses in Mice
    Fatemeh Bakhtiarzadeh, Koorosh Shahpasand, Amir Shojaei, Yaghoub Fathollahi, Nahid Roohi, Vicrotia Barkley, Javad Mirnajafi‐Zadeh · 2023 · Neuroscience
  44. DReAmocracy: A Method to Capitalise on Prior Drug Discovery Efforts to Highlight Candidate Drugs for Repurposing
    Kyriaki Savva, Margarita Zachariou, Marilena M. Bourdakou, Nikolas Dietis, George M. Spyrou · 2024 · International Journal of Molecular Sciences
  45. Concurrent exercise does not prevent recognition memory deficits induced by beta-amyloid in rats
    Karine Ramires Lima, Helen Lidiane Schmidt, Letícia Rossi Daré, Caroline Bitencourt Soares, Luiza Freitas Lopes, Felipe P. Carpes, Pâmela Billig Mello‐Carpes · 2021 · Physiology & Behavior
  46. Age-Related Modifications of Electroencephalogram Coherence in Mice Models of Alzheimer’s Disease and Amyotrophic Lateral Sclerosis
    Vasily Vorobyov, А. Д. Деев, Kirill Chaprov, A. A. Ustyugov, Ekaterina A. Lysikova · 2023 · Biomedicines
  47. In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases
    Daniela Perani, Arianna Sala, Silvia Paola Caminiti, Luca Presotto, Andrea Pilotto, Claudio Liguori, Agostino Chiaravalloti, Valentina Garibotto, Giovanni Battista Frisoni, Marcello D’Amelio et al. · 2021
  48. Functional Connectivity Differences in Distinct Dentato-Cortical Networks in Alzheimer’s Disease and Mild Cognitive Impairment
    Ivan A. Herrejon, Trevor Bryan Jackson, Tracey H. Hicks, Jessica A. Bernard, Alzheimer’s Disease Neuroimaging Initiative · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Compensating functional connectivity changes due to structural connectivity damage via modifications of local dynamics
    Sophie Benitez Stulz, Samy Castro, Grégory Dumont, Boris S Gutkin, Demian A. Battaglia · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Decoding Alzheimer’s disease: acetylcholine and dopamine pathway disruptions as early markers of cognitive decline
    Claudio Zaccone, Annalisa Nobili, Marcello D’Amelio · 2024 · Brain Communications
  51. A Review on the Pathophysiology of Alzheimer’s Disease
    Uma Agarwal, Garima Talwar Kapoor, Rajiv Kumar Tonk · 2025 · Current Protein and Peptide Science
  52. The association of the Wnt/β-catenin signaling pathway with Alzheimer's disease
    Jiaying Ma, Yi Liu, Desheng Lu, Qi Sun · 2025 · Neuropharmacology
  53. Emergent technologies and applications of TMS and TMS-EEG in clinical neurophysiology for early and differential diagnosis: IFCN handbook chapter
    Alberto Benussi, Steve Vucic · 2025 · Clinical Neurophysiology
  54. Emerging role of metabolomics in protein conformational disorders
    Nimisha Gupta, Sreelakshmi Ramakrishnan, Saima Wajid · 2021 · Expert Review of Proteomics
  55. Preparation and characterization of dopamine-loaded bacterial cargo for anti-inflammatory applications
    Anbazhagan Sathiyaseelan, Myeong‐Hyeon Wang · 2023 · Journal of Drug Delivery Science and Technology
  56. How dopamine tunes parvalbumin interneurons in the hippocampus: new experimental observations in Alzheimer’s disease
    Livia La Barbera, Paraskevi Krashia, Annalisa Nobili · 2024 · Neural Regeneration Research
  57. Design, synthesis and evaluation of benzothiazole-derived phenyl thioacetamides as dual inhibitors of monoamine oxidases and cholinesterases
    Sandeep Kumar, Rangan Mitra, Senthil Raja Ayyannan · 2024 · Molecular Diversity
  58. Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease‐modifying agent
    Annalisa Nobili, Marcello D’Amelio · 2025 · Alzheimer s & Dementia
  59. Effect of boswellic acid in Alzheimer’s disease in experimental rat
    Mai M. El-Keiy, Menna Allah M. Youssef, Azza A. Bakry, Tarek Mostafa Mohamed · 2019 · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research
  60. Where Do Artists Come From? A Review of the ‘Typical’ Visually Creative Life and Artistic Brain as a Basis for Discussing Neurodivergence or Neurodegenerative Change
    Matthew J. Pelowski, Rebecca Chamberlain · 2023 · Current clinical neurology
  61. Stress-induced alterations of mesocortical and mesolimbic dopaminergic pathways
    Francis Quessy, Thibault P. Bittar, Léa-Jeanne Blanchette, Martin Lévesque, Benoît Labonté · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  62. RGS6 mediates exercise-induced recovery of hippocampal neurogenesis, learning, and memory in an Alzheimer’s mouse model
    Mackenzie M. Spicer, Jianqi Yang, Daniel Fu, Alison N. DeVore, Marisol Carmela Lauffer, Nilufer S. Atasoy, Deniz Atasoy, Rory Alan Fisher · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Dopamine Dilemma Overexcites the Hippocampus in Alzheimer's Disease
    Jennifer C. Wong · 2024 · Epiliepsy currents/Epilepsy currents
  64. Particulate matter constituents trigger the formation of extracellular amyloid β and Tau -containing plaques and neurite shortening in vitro
    Aleksandar Sebastijanović, Laura M. A. Camassa, Vilhelm Malmborg, Slavko Kralj, Joakim Pagels, Ulla Birgitte Vogel, Shanbeh Zienolddiny, Iztok Urbančič, Tilen Koklič, Janez Štrancar · 2024 · Nanotoxicology
  65. Synaptic and synchronic impairments in subcortical brain regions associated with early non-cognitive dysfunction in Alzheimer’s disease
    Nicolás Riffo-Lepe, Juliana González-Sanmiguel, Lorena Armijo‐Weingart, Paulina Saavedra, David Hernandez, Gerson Ramos, Loreto San Martín, Luis Gerardo Aguayo · 2025 · Neural Regeneration Research
  66. Alzheimer's disease traits in Parkinson's disease without α‐synuclein seeding
    Bárbara Fernandes Gomes, Carly M. Farris, Yihua Ma, Luis Concha‐Marambio, Johanna Nilsson, Karin Forsberg, Russ M. Lebovitz, Ulf Andréasson, Kaj Blennow, Henrik Zetterberg et al. · 2025 · Alzheimer s & Dementia
  67. “Green” carbon dots from coffee waste for adsorption of xenobiotic and trace heavy metals in both aquatic and physiological media
    Natalia V. Krisanova, Konstantin Paliienko, Natalia Pozdnyakova, Artem O. Pastukhov, Mikola Driuk, Liliia Kalynovska, Marina Dudarenko, Arsenii Borysov, Valeriy A. Skryshevsky, Vladimir Lysenko et al. · 2025 · Environmental Science Nano
  68. Photostimulation of locus coeruleus CA1 catecholaminergic terminals reversed Spatial memory impairment in an alzheimer’s disease mouse model
    Donovan K. Gálvez-Márquez, Oscar Urrego-Morales, Luis F. Rodríguez-Durán, Federico Bermúdez‐Rattoni · 2025 · Psychopharmacology
  69. Alterations in neuronal excitability and AMPA-mediated neurotransmission in an APP/PS1 neuronal culture model derived from nucleus accumbens
    Paulina Saavedra, Isaías Meza, Nicolás Riffo-Lepe, Loreto San Martín, Juliana González-Sanmiguel, Luis Gerardo Aguayo · 2025 · Journal of Alzheimer s Disease
  70. Environmental UV filters threaten human neurodevelopment: Disruption of central and peripheral nervous system lineage commitment via WNT signaling dysregulation
    Shichang Li, Shuxian Zhang, Hanyue Li, Nuoya Yin, Renjun Yang, Yang Zhang, Magdalena J. Koziol, Francesco Faiola · 2025 · Journal of Hazardous Materials
  71. Network-level organization of systemic inflammation reflects early Alzheimer’s-like behavioral changes
    Macy A. Seijo, Anisha Banerjee, Caesar M. Hernandez · 2025 · Scientific Reports
  72. Stimulation of Ca 2+ channel Ca V 1.2 activity by dopamine signaling augments spatial working memory
    Kwun Nok Mimi Man, Sarah L. S. Rougé, Ruben A. Berumen, Ariel A. Jacobi, Justin C. Weiner, Shawheen Y. Naderi, Kyle E. Ireton, Zoila M. Estrada‐Tobar, Zhuoer Zeng, Joseph M. Martinez et al. · 2025 · Science Signaling
  73. Norepinephrine and dopamine Imbalance in the medial frontal gyrus from patients with Alzheimer's disease
    Zuleyha Nihan Yurtsever, Silvia Capuani, Michela Fratini, Charles Nicaise, Yasmine Salman, Bernard Jimmy Hanseeuw, Giovanni Augusto Carlesimo, Emanuele Claudio Latagliata, Roberto Coccurello · 2026 · IBRO Neuroscience Reports
  74. Targeting p75NTR activity alleviates the neurotoxic effect of high glucose on iPSC-derived dopaminergic neurons
    Konstantina Chanoumidou, Ioanna Zota, Maria Anna Papadopoulou, Chrystalla Konstantinou, Alexandros Tsimpolis, Electra Tsagliotis, Maria Tziortziou, Katerina Ntarntani, Anne Grünewald, Matthieu D. Lavigne et al. · 2026 · Stem Cell Research & Therapy
  75. Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline
    Jiheng Zhang, Jiren Zhang, Jian Ding, Xian Zhang, Yuhua Wang, Wei Wei, Yan Chai, Shu Zhang, Xin Chen · 2026 · Alzheimer s & Dementia
  76. POINTseq: Cell-type-specific barcoding reveals single-cell projection architecture of the mouse dopaminergic system
    Hyopil Kim, Cheng Xu, Craig Washington, Caleb Shi, Maggie Lowman, Justus M. Kebschull · 2026 · Neuron
  77. Uso dos canabinóides no tratamento de pessoas portadoras de Alzheimer
    Yara Paiva Bittes, Leila Batista Ribeiro, Gleisiane Silva Anselmo, Taynara Câmara Lopes Dantas, Marcus Vinícius Ribeiro Ferreira, Wanderlan Cabral Neves, João de Sousa Pinheiro Barbosa, Danielle Ferreira Silva · 2021 · Revista de Divulgação Científica Sena Aires
  78. Nicotine Abuse and Neurodegeneration: Novel Pharmacogenetic Targets to Aid Quitting and Reduce the Risk of Dementia
    Fatimah A. Almahasneh, Romany H. Gerges, Ejlal M. Abu-El-Rub, Ramada R. Khasawneh · 2023 · CNS & Neurological Disorders - Drug Targets
  79. Potential neural substrates underlying circadian and olfactory disruptions in preclinical Alzheimer’s disease
    Quiana L. Jeffs, Jonathan F. Prather, William D. Todd · 2023 · Frontiers in Neuroscience
  80. Action and Interaction of Amyloid-β and Insulin on Dopamine Release and Reuptake in the Dorsal Lateral Striatum of Rats
    Valery N. Mukhin, Ivan R. Borovets, Vadim V. Sizov, В. М. Клименко · 2024 · Journal of Evolutionary Biochemistry and Physiology
  81. Design, synthesis and evaluation of sesamol-derived acetamides as dual inhibitors of monoamine oxidases and cholinesterases
    Sandeep Kumar, Rangan Mitra, Senthil Raja Ayyannan · 2024 · Medicinal Chemistry Research
  82. Self-assembly Pt hollow nanospheres for highly selective and ultrasensitive detection of dopamine
    Pengjun Duan, Qiaomei Sun, Yihang Xu · 2024 · Microchemical Journal
  83. CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer’s disease spectrum
    Lena Haag, Elisa Lancini, Renat Yakupov, Gabriel Ziegler, Yeo‐Jin Yi, Falk Lüsebrink, Wenzel Glanz, Oliver Peters, Eike Jakob Spruth, Slawek Altenstein et al. · 2024 · Brain Communications
  84. Stereotyped, automatized and habitual behaviours: are they similar constructs under the control of the same cerebral areas?
    Tiziana Marilena Florio · 2020 · AIMS neuroscience
  85. β-lactolin, a Monoamine Oxidase B Inhibitory Lactopeptide, Suppresses Reactive Oxygen Species Production in Lipopolysaccharide-Stimulated Astrocytes
    Shiori Akiyama, Tatsuhiro Ayabe, Chika Takahashi, Rena Ohya, Yasuhisa Ano · 2021 · Applied Sciences
  86. Distinct effects of amyloid and tau deposition on eigenvector centrality during hippocampal down-regulation: a real-time fMRI virtual reality closed-loop neurofeedback study with CSF biomarkers
    Stavros Skouras, Jordi Torner, Patrik Andersson, Yury Koush, Carles Falcón, Carolina Minguillón, Karine Fauria, Francesc Alpiste, Kaj Blenow, Henrik Zetterberg et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Genetic reduction of PERK-eIF2α signaling in dopaminergic neurons drives cognitive and age-dependent motor dysfunction
    Francesco Longo, Maria Mancini, Pierre L. Ibraheem, Sameer Aryal, Caterina Mesini, Jyoti C. Patel, Elena Penhos, Nazia Rahman, Maggie Donohue, Emanuela Santini et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Early Tactile Stimulation Influences the Development of Alzheimer Disease in Gestationally Stressed APP NL-G-F Adult Offspring NL-G-F/NL-G-F mice
    Shakhawat R. Hossain, Hadil Karem, Zahra Jafari, Bryan E Kolb, Majid H. Mohajerani · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Stress-induced Alterations of Mesocortical and Mesolimbic Dopaminergic Pathways
    Francis Quessy, Thibault P. Bittar, Léa-Jeanne Blanchette, Martin Lévesque, Benoît Labonté · 2021 · Research Square
  90. Emerging approaches for the treatment of Alzheimer disease: Targeting NF-κB pathway
    A S Goel, Shamsher Singh · 2020
  91. A Novel Human TBCK- Neuronal Cell Model Results in Severe Neurodegeneration and Partial Rescue with Mitochondrial Fission Inhibition
    Rajesh Angireddy, Bhanu Chandra Karisetty, Kaitlin A. Katsura, Abdias Diaz‐Rosado, Svathi Murali, Sarina M. Smith, Laura Ohl, Kelly Clark, Andrew V. Kossenkov, Elizabeth J. K. Bhoj · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Toward Precise Modeling of Dopamine Release Kinetics: Comparison and Validation of Kinetic Models Using Voltammetry
    Abhinav Goyal, Una Karanovic, Charles D. Blaha, Kendall H. Lee, Hojin Shin, Yoonbae Oh · 2024 · ACS Omega
  93. Cranial volume measurement with artificial intelligence and cognitive scales in patients with clinically isolated syndrome
    Özlem Yalınkaya Albuz, İbrahim Acır, Ozan Haşimoğlu, Melis Suskun, Elif Hocaoğlu, Vıldan Yayla · 2024 · Frontiers in Neurology
  94. Dopamine increases protein synthesis in hippocampal neurons enabling dopamine-dependent LTP
    Tanja Fuchsberger, Imogen Stockwell, Matty Woods, Zuzanna Brzosko, Ingo H. Greger, Ole Paulsen · 2025 · eLife
  95. Parallel Gene Expression Changes in Ventral Midbrain Dopamine and GABA Neurons during Normal Aging
    Ana Luiza Drumond‐Bock, Harris E. Blankenship, Kevin D. Pham, Kelsey A Carter, Willard M. Freeman, Michael J. Beckstead · 2025 · eNeuro
  96. Lipid carrier-based intranasal delivery of calcium channel blockers for Alzheimer’s disease
    Sunil Jog, Sayali Dighe, Khushali Nathani, Akanksha Waghmare, Shubhada V Mangrulkar, Sujata Pralhad Sawarkar, Abdelwahab Omri · 2025 · Expert Opinion on Drug Delivery
  97. Neuroplasticity and Alzheimer’s Disease
    Ashkan Asgari Gashtrodkhani, Samaneh Ghorbani Shirkouhi, Seyed Sepehr Khatami, Farzin Kamari, Sarvenaz Ghaedi, Morten Blaabjerg, Sasan Andalib · 2026 · Journal of Integrative Neuroscience
  98. pH-Dependent Oxidase- and Hydrolase-Mimicking Activity of Nanoceria and Its Composite with Nitrogen-Doped Carbon Quantum Dots for Sensitive Detection of Dopamine, Glutathione, and Methyl Paraoxon
    Yogyata Chawre, Manmohan Lal Satnami, Ankita Beena Kujur, Akash Sinha, Prince Kumar Soni, Pinki Miri, Rekha Nagwanshi, Indrapal Karbhal, Kallol Kumar Ghosh · 2026 · ACS Chemical Neuroscience
  99. Neuromodulation techniques targeting neurotransmitter dysfunction: Innovation in treatments for Alzheimer’s disease
    Siyuan Jin, Bingqi Guo, Wensi Hao, Xin Su, T Zhang, Chen Liu · 2025 · Neural Regeneration Research
  100. Simulation of Neurotransmitter Release and Its Imaging by Fluorescent Sensors
    Juliana Gretz, Jennifer M. Mohr, Björn Hill · 2026 · ACS Chemical Neuroscience